Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and ...

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

MUMBAI, India, March 2, 2021 /CNW/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug ...

Generic name: Sumatriptan transport - oral. Sumatriptan is used to reduce migraines. Sumatriptan belongs to a very of drugs known differin purchase online triptans. Generic Imitrex Sumatriptan is a ...

NEW YORK (MarketWatch) -- Mylan Laboratories Inc., the Pittsburgh drugmaker, said the U.S. Food and Drug Administration tentatively cleared Mylan's abbreviated new-drug application for sumatriptan ...

Tosymra (sumatriptan) is a brand-name drug that’s prescribed to treat migraine with or without aura in adults. Tosymra comes as a nasal spray that’s used when needed to manage a migraine episode.

TEL AVIV, Nov 29 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd. said on Wednesday the U.S. Food and Drug Administration has granted tentative approval for the company's sumatriptan succinate ...

NEW DELHI, Feb 10 (Reuters) - Ranbaxy Laboratories , India's top drugmaker by sales, has received the U.S. Food and Drug Administration's approval to sell acute migraine drug sumatriptan, a spokesman ...